<DOC>
	<DOCNO>NCT00122681</DOCNO>
	<brief_summary>Human Papilloma virus ( HPV ) viruses cause common infection skin genitals men woman . Several type HPV infection transmit sexual activity , woman , infect cervix ( part uterus womb ) . This infection often go away , go away ( call persistent infection ) , lead woman long period time cancer cervix . If woman infect HPV , unlikely get cervical cancer . This study evaluate efficacy GSK Biologicals HPV 16/18 VLP/AS04 vaccine prevent infection associate cervical pre-cancer vaccine HPV 16 18 vaccine safety , 48 month , young adolescent woman 15/25 year age study start . Approximately 18.000 study subject either receive HPV vaccine control vaccine ( hepatitis A vaccine ) administer intramuscularly accord 0-1-6 month schedule . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Human Papilloma Virus ( HPV ) Vaccine Efficacy Trial Against Cervical Pre-cancer Young Adults With GlaxoSmithKline ( GSK ) Biologicals HPV-16/18</brief_title>
	<detailed_description>NOTE : Some 178 center participate study . Given recruitment complete , researcher list one center per country website . If require , detail center available request .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A woman investigator believe and/or parents/legally acceptable representative comply requirement protocol ( e.g. , completion diary card , return followup visit ) . A woman , include , 15 25 year age time first vaccination . Written informed consent must obtain subject prior enrollment ( subject legal age consent , write informed consent must obtain parent legal guardian subject , addition , subject sign personally date write informed assent ) . Subject must free obvious health problem establish medical history clinical examination enter study . Subject must negative urine pregnancy test . Subject must nonchildbearing potential , childbearing potential , must abstinent must use adequate contraceptive precaution 30 day prior first vaccination must agree continue precaution two month completion vaccination series . Has 6 lifetime sexual partner prior enrollment . This criterion may applicable subject less 18 year age , accord local regulatory/ethical requirement . Subject must intact cervix . Pregnant breastfeeding . Women must least 3 month postpregnancy breastfeed enter study . A woman plan become pregnant planning discontinue contraceptive precaution approximately first nine month study ( Months 08 ) . Previous administration component investigational vaccine . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug within six month prior first vaccine dose . Planned administration/administration vaccine foreseen study protocol within 30 day 30 day ( i.e . day 029 ) dose vaccine . Administration routine vaccine 8 day dose study vaccine allow . Enrolment defer subject outside specify window . Previous vaccination human papillomavirus ( HPV ) . History vaccination Hepatitis A known clinical history Hepatitis A disease . History colposcopy plan colposcopy evaluate abnormal cervical cytology ( Pap smear ) test . Any medically diagnose suspect immunodeficient condition base medical history physical examination . History allergic disease , suspect allergy reaction likely exacerbate component study vaccine . Hypersensitivity latex . Known acute chronic , clinically significant pulmonary , cardiovascular , neurologic , hepatic renal functional abnormality , determine previous physical examination laboratory test . History chronic condition ( ) require treatment . Received immunoglobulin and/or blood product within 90 day precede enrollment . Enrollment defer subject outside specify window . Acute disease time enrolment . Heavy bleeding ( menstruation ) heavy vaginal discharge pelvic exam perform . Enrollment deferred condition resolve accord investigator 's medical judgement .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>